| Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. | |
| | |
MedLine Citation:
|
PMID: 21883602 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Aims: To examine the cost-effectiveness of personal smoking cessation support in Vietnam. Design, setting and participants: We followed up the population aged 15 and over in 2006 to model the costs and health gains associated with five interventions: physician brief advice; nicotine replacement therapy (patch and gum); Bupropion; and Varenicline. Threshold analysis was undertaken to determine the price levels of pharmaceuticals for the interventions to be cost-effective. A multi-state life table model was constructed such that the interventions affect the smoking cessation behaviour of the age cohorts, and the resulting smoking prevalence defines their health outcomes. A healthcare perspective was employed. Measurements: Cost-effectiveness is measured in 2006 Vietnamese Dong (VND) per disability-adjusted life year (DALY) averted. We adopted the WHO thresholds of being "cost-effective" if less than 3 times GDP per capita (VND 34,600,000) and "very cost-effective" if less than GDP per capita (VND 11,500,000). Findings: The cost-effectiveness result of physician brief advice was VND 1,583,000 per DALY averted (Int. $493), which was "very cost-effective". Varenicline dominated Bupropion and nicotine-replacement therapies, although it did not fall within the range of being "cost-effective" under different scenarios. The threshold analysis revealed that prices of pharmaceuticals must be substantially lower than the levels from other countries if pharmacological therapies are to be cost-effective in Vietnam. Conclusions: Physician brief advice is a cost-effective intervention and should be included in the priority list of tobacco control policy in Vietnam. Pharmacological therapies are not cost-effective, and so they are not recommended in Vietnam at this time unless pharmaceuticals would be produced locally at substantially lower costs in the future. |
| | |
Authors:
|
Hideki Higashi; Jan J Barendregt |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-23 |
Journal Detail:
|
Title: Addiction (Abingdon, England) Volume: - ISSN: 1360-0443 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-9-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304118 Medline TA: Addiction Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction. |
Affiliation:
|
The University of Queensland, School of Population Health, Herston, QLD 4006, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: ...
Next Document: THE EFFECT OF METHADONE ON EMOTIONAL REACTIVITY.